Pamela Kunz, MD, is Director of the Center for Gastrointestinal Cancers at Smilow Cancer Hospital at Yale New Haven and Yale Cancer Center; Chief of GI Medical Oncology within the Section of Medical Oncology; and Vice Chief of Diversity, Equity, and Inclusion, Medical Oncology. A GI medical oncologist, Dr. Kunz is an international leader in the clinical care of patients with neuroendocrine tumors (NETs) and is advancing the field through clinical trials and translational science that are defining the next generation of therapies for patients with this rare diagnosis.
Dr. Kunz serves as Vice President for the North American Neuroendocrine Tumor Society (NANETS). Prior to joining the team at Yale, Dr. Kunz was Director of the Neuroendocrine Tumor Program, Leader of the Endocrinology Oncology Research Group, and Director of the Neuroendocrine Tumor Fellowship at Stanford University School of Medicine.
Women Leaders in Oncology (WLO) named Dr. Kunz the 2021 Woman Oncologist of the Year. This award “honors a senior professional who is a respected individual in her field and who has modeled excellence in leadership. It also recognizes a woman who exhibits strong business acumen and the ability to share her skills with others.”
To learn what inspired Dr. Kunz to become a doctor and her approach when caring for patients, CLICK HERE.
